ADC Therapeutics To Wind Up Zynlonta Study In Frail Patients After Deaths

Study To End Despite No Clear Link With Treatment

 
• By Andrew McConaghie
  
Frail Patient
The study aimed to help elderly patients who were frail and unfit for standard first line chemotherapy treatment.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip